CAR T-cell therapy approved to treat certain children and young adults with B-cell acute lymphoblastic leukemia
U.S. FDA, August 30, 2017 –Â The U.S. Food and Drug Administration issued a historic action today making the first gene therapy available in the United States, ushering in a new approach to the treatment of cancer and other serious and life-threatening diseases. [Read more…]